Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Seminars in Immunology|November 14, 2022
Development of γδ T cells in the thymus - A human perspectiveLena Boehme, Juliette Roels, Tom TaghonThe Journal of Allergy and Clinical Immunology|June 25, 2025
Thymic pioneers: Charting the origin, identity, and fate of human thymus seeding progenitorsKai Ling Liang, Lena Boehme, Silke Paepens, et al.Elife|February 19, 2019
Nuclear genetic regulation of the human mitochondrial transcriptomeAminah T Ali, Lena Boehme, Guillermo Carbajosa, et al.Nature Communications|October 30, 2020
Intellectual disability-associated factor Zbtb11 cooperates with NRF-2/GABP to control mitochondrial functionBrooke C Wilson, Lena Boehme, Ambra Annibali, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2022
Defective STAT5 Activation and Aberrant Expression of BCL6 in Naive CD4 T Cells Enhances Follicular Th Cell-like Differentiation in Patients with Granulomatosis with PolyangiitisSangmi Kim, Lena Boehme, Louise Nel, et al.Frontiers in Immunology|August 15, 2022
Transcriptional dynamics and epigenetic regulation of E and ID protein encoding genes during human T cell developmentJuliette Roels, Jolien Van Hulle, Marieke Lavaert, et al.Haematologica|April 4, 2024
<i>HES6</i>knockdown in human hematopoietic precursor cells reduces their <i>in vivo</i> engraftment potential and their capacity to differentiate into erythroid cells, B cells, T cells and plasmacytoid dendritic cellsTamara De Vos, Nicole Oatman, Lena Boehme, et al.British Journal of Cancer|June 26, 2021
A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanomaOscar Maiques, Bruce Fanshawe, Eva Crosas-Molist, et al.Cancer Cell|January 15, 2020
Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy ResistanceJose L Orgaz, Eva Crosas-Molist, Amine Sadok, et al.Cell Reports|February 14, 2026
In vivo modeling of human γδ T cell ontogeny reveals terminal deoxynucleotidyl transferase as a key regulator of type 3 Vδ2 T cell developmentCéline La, Aurélie Detavernier, Maria Papadopoulou, et al.Pageof 2